Invention Grant
- Patent Title: Multi-specific binding conjugate, related pharmaceutical compositions and use
-
Application No.: US16130031Application Date: 2018-09-13
-
Publication No.: US11000603B2Publication Date: 2021-05-11
- Inventor: Haoyang Yu , Zhengcheng Li , Jing Su
- Applicant: Benhealth Biopharmaceutic (Shenzhen) Co., Ltd.
- Applicant Address: CN Guangdong
- Assignee: Benhealth Biopharmaceutic (Shenzhen) Co., Ltd.
- Current Assignee: Benhealth Biopharmaceutic (Shenzhen) Co., Ltd.
- Current Assignee Address: CN Guangdong
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: CN201510175130.3 20150414,WOPCT/CN2016/080749 20160429
- Main IPC: A61K47/69
- IPC: A61K47/69 ; C07K16/28 ; A61K35/17 ; A61K45/06 ; A61K39/395 ; A61K47/59 ; A61P35/00 ; A61K47/68 ; C07K16/30 ; A61K39/00

Abstract:
The present invention relates to a multi-specific binding conjugate, a related composition and use. The binding conjugate comprises binding moieties for two or more different receptors, co-receptors, antigens or cellular markers which moieties are coupled by a nanomaterial. The multi-specific binding conjugate can be used to modulate an immune response, treat or prevent a disease or condition (e.g., a cancer, autoimmune disease, pathogen infection or inflammatory disease).
Public/Granted literature
- US20180369411A1 MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE Public/Granted day:2018-12-27
Information query